Login
$PMN
$3.25 -$0.06 (1.81%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Neil Warma Also a director
Chief Executive Officer
63 Not stated $830,168
Daniel Geffken
Chief Financial Officer
69 Since 2017
9 years
Not reported
Neil Cashman Also a director
Chief Scientific Officer
74 Not stated Not reported
Larry Altstiel
Chief Medical Officer
76 Since 2022
4 years
$544,196
Johanne Kaplan
Chief Development Officer
66 Since 2016
10 years
$581,863
Ivana Rubino
Chief Commercial Officer
Title from the Form 4 dated Oct 5, 2026
Not stated Not stated Not reported
Max A. Milbury
Principal Accounting Officer
Title from the Form 4 dated May 20, 2026
Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
4 of 4
stated in the proxy; 4 not stated
Average tenure
7.9 years
from year joined
CEO also chairs the board
No
Eugene Williams
Director Age On board Independent 2025 pay Source
Eugene Williams
66 2015
11 years
Not stated $226,666
Neil Warma
63 2021
5 years
Not stated Paid as CEO
Maggie Shafmaster
67 2021
5 years
Independent $57,916
Neil Cashman
74 2010
16 years
Not stated Not stated
William Wyman
88 2014
12 years
Independent $71,916
Josh Mandel-Brehm
43 2021
5 years
Independent $63,416
Slanix Alex
36 2025
1 year
Independent $7,717
Patrick Kirwin Leaving at the meeting
Not stated Not stated Not stated $59,416

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

16 disclosed in the proxy filed Apr 9, 2026
Neil Cashman
Chief Scientific Officer
$428,860 and $605,645
2025 and 2024

Collaborative research agreement with UBC and Vancouver Coastal Health Authority; Company made cash payments under it

With University of British Columbia Open in proxy
Eugene Williams
consultant to the Company under the Williams Consulting Agreement
$168,750 and $225,000
2025 and 2024

Strategic services consulting agreement; cash consulting fees paid to Mr. Williams

Entities Affiliated with Janus Henderson
$14,999,983
January 2026

Private offering purchase of Common Shares, pre-funded warrants and Warrants

Entities Affiliated with Ally Bridge Group
$8,499,988
January 2026

Private offering purchase of Common Shares and warrants

Entities Affiliated with Ally Bridge Group
$5,469,468
July 2025

Private offering warrant exercise and acquisition of warrants

Entities Affiliated with Deep Track
$9,000,004
January 2026

Private offering purchase of Common Shares and warrants

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
$7,499,991
January 2026

Private offering purchase of Common Shares and warrants

Trails Edge Biotechnology Master Fund, LP
$5,999,999
January 2026

Private offering purchase of Common Shares and warrants

Entities Affiliated with Great Point
$4,000,000
January 2026

Private offering purchase of Common Shares and warrants

Entities Affiliated with Sphera
$3,500,002
January 2026

Private offering purchase of Common Shares and warrants

Entities Affiliated with Jeremy Sclar
$2,499,997
January 2026

Private offering purchase of Common Shares and warrants

Entities Affiliated with Jeremy Sclar
$2,336,713
July 2025

Private offering warrant exercise and acquisition of warrants

Woodline Master Fund LP
$4,000,000
January 2026

Private offering purchase of Common Shares and warrants

Shaf QIC, LLC
$1,399,992
January 2026

Private offering purchase of Common Shares and warrants

Shaf QIC, LLC
$784,884
July 2025

Private offering warrant exercise and acquisition of warrants

Squadron Master Fund LP
$3,500,002
January 2026

Private offering purchase of Common Shares and warrants

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support